New pharmacologic approaches to spinal cord injury: opiate antagonists and thyrotropin-releasing hormone.
D000818:Animals; D001392:Azocines / Q000494:pharmacology / Q000627:therapeutic use; D002415:Cats; D004723:Endorphins / Q000502:physiology; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009270:Naloxone / Q000008:administration & dosage / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology; D013119:Spinal Cord Injuries / Q000188:drug therapy* / Q000503:physiopathology; D053778:Thiazolidines; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*
D001392:Azocines; D004723:Endorphins; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D053778:Thiazolidines; D009270:Naloxone; D004743:Enkephalin, Leucine; D013973:Thyrotropin-Releasing Hormone; C021597:pyro(l-alpha-aminoadipyl)-L-histidyl-L-thiazolidine-4-carboxamide; C036405:ICI 154129; C035969:quadazocine